Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients

Journal of Assisted Reproduction and Genetics

Volumn 25, Issue 2-3, 2008, Pages 89-93

  Duvan, Candan Iltemir ^a   Berker, Bulent ^b   Turhan, Nilgun Ozturk ^a   Satiroglu, Hakan ^b  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Intra cytoplasmic sperm injection; Microdose GnRH a; Oral contraceptive; Poor responder

Indexed keywords

CHORIONIC GONADOTROPIN; DESOGESTREL; ESTRADIOL; ETHINYLESTRADIOL; GONADORELIN; LEUPRORELIN; MYRALON; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE RETRIEVAL; ORAL CONTRACEPTION; PREGNANCY RATE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

EID: 40149106906     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-008-9203-8     Document Type: Article

References (24)

1. 1. ES Surrey J Bower DM Hill J Ramsey MW Surrey 1998 Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization Fertil Steril. 69 3 419 424 9531870 10.1016/S0015-0282(97)00575-X 1:STN:280:DyaK1c7ptlShsw%3D%3D Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril. 1998;69(3):419–24. Mar.
2. 2. JM Jenkins DW Davies H Devonport FW Anthony SC Gadd RH Watson GM Masson 1991 Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization Hum Reprod. 6 7 918 921 1761658 1:STN:280:By2C3crjtVY%3D Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM. Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod. 1991;6(7):918–21. Aug.
3. 3. Z Ben-Rafael D Bider U Dan M Zolti D Levran S Mashiach 1991 Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG J In Vitro Fert Embryo Transf. 8 1 33 36 1826724 10.1007/BF01131588 1:STN:280:By6B3c3gtVw%3D Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf. 1991;8(1):33–6. Feb.
4. 4. RT Scott D Navot 1994 Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization Fertil Steril. 61 5 880 885 8174725 1:STN:280:ByuB38bis1A%3D Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril. 1994;61(5):880–5. May.
5. 5. SL Tan N Maconochie P Doyle S Campbell A Balen J Bekir P Brinsden RG Edwards HS Jacobs 1994 Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin Am J Obstet Gynecol. 171 2 513 520 8059833 1:STN:280:ByuA3sjotlw%3D Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, Brinsden P, Edwards RG, Jacobs HS. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol. 1994;171(2):513–20. Aug.
6. 6. K Droesch SJ Muasher RG Brzyski GS Jones S Simonetti HC Liu Z Rosenwaks 1989 Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization Fertil Steril. 51 2 292 297 2492234 1:STN:280:BiaC3cjlvFA%3D Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril. 1989;51(2):292–7. Feb.
7. 7. EG Hughes DM Fedorkow S Daya MA Sagle P Koppel Van de JA Collins 1992 The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials Fertil Steril. 58 5 888 896 1426372 1:STN:280:ByyD2M%2FjsVY%3D Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 1992;58(5):888–96. Nov.
8. 8. BM Faber J Mayer B Cox D Jones JP Toner S Oehninger SJ Muasher 1998 Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders Fertil Steril. 69 5 826 830 9591487 10.1016/S0015-0282(98)00040-5 1:STN:280:DyaK1c3lt1Wlsw%3D%3D Faber BM, Mayer J, Cox B, Jones D, Toner JP, Oehninger S, Muasher SJ. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril. 1998;69(5):826–30. May.
9. 9. ES Surrey WB Schoolcraft 2000 Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques Fertil Steril. 73 4 667 676 10731523 10.1016/S0015-0282(99)00630-5 1:STN:280:DC%2BD3c7pvVSqsg%3D%3D Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73(4):667–76. Apr.
10. 10. E Caspi R Ron-El A Golan H Nachum A Herman Y Soffer Z Weinraub 1989 Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins Fertil Steril. 51 1 95 99 2521328 1:STN:280:BiaD1M7kvFI%3D Caspi E, Ron-El R, Golan A, Nachum H, Herman A, Soffer Y, Weinraub Z. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. Fertil Steril. 1989;51(1):95–9. Jan.
11. 11. JM Jenkins FW Anthony P Wood D Rushen GM Masson E Thomas 1993 The development of functional ovarian cysts during pituitary down-regulation Hum Reprod. 8 10 1623 1627 8300817 1:STN:280:ByuC3s3islQ%3D Jenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E. The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod. 1993;8(10):1623–7. Oct.
12. 12. JE Garcia SL Padilla J Bayati TA Baramki 1990 Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization Fertil Steril. 53 2 302 305 2105247 1:STN:280:By%2BC38jkvVE%3D Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril. 1990;53(2):302–5. Feb.
13. 13. SL Padilla K Dugan V Maruschak S Shalika RD Smith 1996 Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders Fertil Steril. 65 4 796 799 8654641 1:STN:280:BymB28jgtlY%3D Padilla SL, Dugan K, Maruschak V, Shalika S, Smith RD. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril. 1996;65(4):796–9. Apr.
14. 14. RG Forman J Demouzon MC Feinstein J Testart R Frydman 1991 Studies on the influence of gonadotrophin levels in the early follicular phase on the ovarian response to stimulation Hum Reprod. 6 1 113 117 1908489 1:CAS:528:DyaK3MXlsFSktbw%3D Forman RG, Demouzon J, Feinstein MC, Testart J, Frydman R. Studies on the influence of gonadotrophin levels in the early follicular phase on the ovarian response to stimulation. Hum Reprod. 1991;6(1):113–7. Jan.
15. 15. I Cedrin-Durnerin S Bulwa F Herve B Martin-Pont M Uzan JN Hugues 1996 The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment Hum Reprod. 11 9 1859 1863 8921054 1:CAS:528:DyaK28XmvF2gtLY%3D Cedrin-Durnerin I, Bulwa S, Herve F, Martin-Pont B, Uzan M, Hugues JN. The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod. 1996;11(9):1859–63. Sep.
16. 16. Y Gonen W Jacobson RF Casper 1990 Gonadotropin suppression with oral contraceptives before in vitro fertilization Fertil Steril. 53 2 282 287 2105244 1:STN:280:By%2BC38jkvVY%3D Gonen Y, Jacobson W, Casper RF. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril. 1990;53(2):282–7. Feb.
17. 17. KA Burry LH Greenberg PE Patton 1991 Ovarian response in superovulated cycles after suppression with oral contraceptive steroids Am J Obstet Gynecol. 164 6 Pt 1 1592 1595 2048606 1:STN:280:By6B28vgsVY%3D Burry KA, Greenberg LH, Patton PE. Ovarian response in superovulated cycles after suppression with oral contraceptive steroids. Am J Obstet Gynecol. 1991;164(6 Pt 1):1592–5. discussion 1595–6 Jun.
18. 18. MM Biljan NG Mahutte N Dean R Hemmings F Bissonnette SL Tan 1998 Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues J Assist Reprod Genet. 15 10 599 604 9866068 10.1023/A:1020381310860 1:STN:280:DyaK1M%2Fotlejsg%3D%3D Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. J Assist Reprod Genet. 1998;15(10):599–604. Nov.
19. 19. MA Damario L Barmat HC Liu OK Davis Z Rosenwaks 1997 Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients Hum Reprod. 12 11 2359 2365 9436663 10.1093/humrep/12.11.2359 1:STN:280:DyaK1c%2FpslWlsQ%3D%3D Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod. 1997;12(11):2359–65. Nov.
20. 20. E Al-Mizyen L Sabatini AM Lower CM Wilson T al-Shawaf JG Grudzinskas 2000 Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET? J Assist Reprod Genet. 17 3 140 146 10911573 10.1023/A:1009462004650 1:STN:280:DC%2BD3M%2FisFyruw%3D%3D Al-Mizyen E, Sabatini L, Lower AM, Wilson CM, al-Shawaf T, Grudzinskas JG. Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET? J Assist Reprod Genet. 2000;17(3):140–6. Mar.
21. 21. P Kovacs PE Barg BR Witt 2001 Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles J Assist Reprod Genet. 18 7 391 394 11499324 10.1023/A:1016626607387 1:STN:280:DC%2BD3MvlsVWlsA%3D%3D Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet. 2001;18(7):391–4. Jul.
22. 22. SR Lindheim DH Barad B Witt E Ditkoff MV Sauer 1996 Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation J Assist Reprod Genet. 13 9 745 747 8947826 10.1007/BF02066431 1:STN:280:ByiC3czksFE%3D Lindheim SR, Barad DH, Witt B, Ditkoff E, Sauer MV. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet. 1996;13(9):745–7. Oct.
23. 23. CA Benadiva Z Ben-Rafael L Blasco R Tureck L Mastroianni Jr GL Flickinger 1988 Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives Fertil Steril. 50 3 516 518 3137106 1:STN:280:BieA3Mzht1E%3D Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril. 1988;50(3):516–8. Sep.
24. 24. TA Klein DR Mishell 1977 Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives Am J Obstet Gynecol. 127 6 585 589 842583 1:CAS:528:DyaE2sXhs1Gkt7g%3D Klein TA, Mishell DR. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives. Am J Obstet Gynecol. 1977;127(6):585–9. Mar 15.